Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Current pharmacotherapies of alcoholism: a U.S. perspective.

Anton RF, Swift RM.

Am J Addict. 2003;12 Suppl 1:S53-68. Review.

PMID:
14972780
2.

[The pharmacologic treatment of the alcohol dependence].

Castro LA, Baltieri DA.

Rev Bras Psiquiatr. 2004 May;26 Suppl 1:S43-6. Epub 2005 Jan 4. Portuguese.

3.

Recent advances in the pharmacotherapy of alcoholism.

Myrick H, Anton R.

Curr Psychiatry Rep. 2004 Oct;6(5):332-8. Review.

PMID:
15355755
4.

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.

Kranzler HR, Van Kirk J.

Alcohol Clin Exp Res. 2001 Sep;25(9):1335-41.

PMID:
11584154
5.

Medications to treat alcoholism.

Johnson BA, Ait-Daoud N.

Alcohol Res Health. 1999;23(2):99-106. Review.

PMID:
10890803
6.

Neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

Johnson BA, Ait-Daoud N.

Psychopharmacology (Berl). 2000 May;149(4):327-44. Review.

PMID:
10867960
7.

New pharmacotherapies for alcohol dependence.

Graham R, Wodak AD, Whelan G.

Med J Aust. 2002 Jul 15;177(2):103-7. Review.

PMID:
12098353
8.

The pharmacological treatment of alcohol dependence.

Swift RM.

Med Health R I. 1997 Mar;80(3):91-3. Review. No abstract available.

PMID:
9117944
9.

Pharmacological treatment of alcohol dependence: a review of the evidence.

Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT.

JAMA. 1999 Apr 14;281(14):1318-25.

PMID:
10208148
10.

Alternatives to naltrexone in animal models.

Overstreet DH.

Alcohol Clin Exp Res. 1996 Nov;20(8 Suppl):231A-235A. No abstract available.

PMID:
8947271
11.

[Neurobiological mechanisms and pharmacological treatment options for alcohol craving].

Hillemacher T, Kornhuber J, Bleich S.

Fortschr Neurol Psychiatr. 2007 Jan;75(1):26-32. Epub 2006 Oct 10. Review. German.

PMID:
17031777
12.

Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.

Rösner S, Leucht S, Lehert P, Soyka M.

J Psychopharmacol. 2008 Jan;22(1):11-23. doi: 10.1177/0269881107078308.

PMID:
18187529
13.
14.

Does the alcoholic's remedy come in a pill?

Gordon SM.

Behav Healthc Tomorrow. 2001 Aug;10(4):SR29-30, SR34. No abstract available.

PMID:
11496583
15.

Occurrence and management of depression in the context of naltrexone treatment of alcoholism.

Farren CK, O'Malley SS.

Am J Psychiatry. 1999 Aug;156(8):1258-62. No abstract available.

PMID:
10450269
16.

New developments in the pharmacotherapy of alcohol dependence.

Myrick H, Brady KT, Malcolm R.

Am J Addict. 2001;10 Suppl:3-15. Review.

PMID:
11268820
17.

Pharmacotherapy for alcohol dependence: status of current treatments.

Franck J, Jayaram-Lindström N.

Curr Opin Neurobiol. 2013 Aug;23(4):692-9. doi: 10.1016/j.conb.2013.05.005. Epub 2013 Jun 26. Review.

PMID:
23810221
18.

Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.

Rubio G, Jiménez-Arriero MA, Ponce G, Palomo T.

Alcohol Alcohol. 2001 Sep-Oct;36(5):419-25. Erratum in: Alcohol Alcohol 2002 Jan-Feb;37(1):105.

PMID:
11524308
19.

Trends in the adoption of medications for alcohol dependence.

Ducharme LJ, Knudsen HK, Roman PM.

J Clin Psychopharmacol. 2006 Dec;26 Suppl 1:S13-9. Review.

PMID:
17114950
20.

Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?

Richardson K, Baillie A, Reid S, Morley K, Teesson M, Sannibale C, Weltman M, Haber P.

Addiction. 2008 Jun;103(6):953-9. doi: 10.1111/j.1360-0443.2008.02215.x.

PMID:
18482418

Supplemental Content

Support Center